Related Experiment Videos
Flow cytometry detection and evaluation of bladder tumors
1Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association
|September 1, 1990
Summary
Flow cytometry accurately detects bladder cancer by measuring DNA content, proving valuable for monitoring high-risk patients and treatment effectiveness. This method offers an alternative to traditional cytology.
Area of Science:
- Uro-oncology
- Medical diagnostics
- Biotechnology
Background:
- Bladder cancer diagnosis traditionally relies on microscopy.
- Cytologic alterations like abnormal DNA content are key indicators.
- Flow cytometry offers quantitative DNA analysis.
Purpose of the Study:
- To evaluate the efficacy of flow cytometry in bladder cancer detection.
- To assess its utility in monitoring high-risk populations and treatment response.
Main Methods:
- Flow cytometry analysis of DNA content in bladder tumor cells and irrigation specimens.
- Comparison of flow cytometry results with clinical and biopsy findings.
- Evaluation of false-positive rates in non-neoplastic bladder disease.
Main Results:
- Flow cytometry detected 83% of bladder cancers in one study.
- The technique shows high sensitivity for early-stage and superficial cancers.
- Low false-positive rates were reported in patients without bladder cancer.
Conclusions:
- Flow cytometry is a valuable tool for bladder cancer diagnosis and monitoring.
- It is particularly useful for high-risk populations and assessing treatment outcomes.
- Future research includes dual parameter measurements for enhanced prediction of clinical behavior.